Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News MSD reveals Rotateq and Gardasil uptake by CDC

MSD reveals Rotateq and Gardasil uptake by CDC

17th July 2007

MSD has announced that its Rotateq and Gardasil vaccines have been selected for use by the Centers for Disease Control and Prevention (CDC) in the US.

The CDC is to include the therapies in its Vaccines for Children programme, which conducts immunisation across all 50 US states and in five major cities in the country.

Children targeted by the scheme include those with no medical insurance or whose insurance is insufficient to afford the treatments privately.

"This milestone is an important step in Merck’s ongoing commitment to make our vaccines available to all children who need them, regardless of income," said Dr Mark Feinberg, vice-president of policy, public health and medical affairs at MSD’s Merck Vaccines division.

"The adoption of Rotateq and Gardasil by all 55 immunisation projects further demonstrates the value these vaccines provide," he added.

Gardasil is given as three injections over the course of six months and protects against diseases caused by human papillomavirus such as cervical cancer, MSD states.ADNFCR-1050-ID-18213745-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.